Importance Physician assistants (PAs) are increasingly used in dermatology practices to diagnose skin cancers, although, to date, their diagnostic accuracy compared with board-certified dermatologists has not been well studied. Objective To compare diagnostic accuracy for skin cancer of PAs with that of dermatologists. Design, Setting, and Participants Medical record review of 33 647 skin cancer screening examinations in 20 270 unique patients who underwent screening at University of Pittsburgh Medical Center–affiliated dermatology offices from January 1, 2011, to December 31, 2015. International Classification of Diseases, Ninth Revision code V76.43 and International Classification of Diseases and Related Health Problems, Tenth Revision code Z12.83 were used to identify pathology reports from skin cancer screening examinations by dermatologists and PAs. Exposure Examination performed by a PA or dermatologist. Main Outcomes and Measures Number needed to biopsy (NNB) to diagnose skin cancer (nonmelanoma, invasive melanoma, or in situ melanoma). Results Of 20 270 unique patients, 12 722 (62.8%) were female, mean (SD) age at the first visit was 52.7 (17.4) years, and 19 515 patients (96.3%) self-reported their race/ethnicity as non-Hispanic white. To diagnose 1 case of skin cancer, the NNB was 3.9 for PAs and 3.3 for dermatologists (P < .001). Per diagnosed melanoma, the NNB was 39.4 for PAs and 25.4 for dermatologists (P = .007). Patients screened by a PA were significantly less likely than those screened by a dermatologist to be diagnosed with melanoma in situ (1.1% vs 1.8% of visits, P = .02), but differences were not significant for invasive melanoma (0.7% vs 0.8% of visits, P = .83) or nonmelanoma skin cancer (6.1% vs 6.1% of visits, P = .98). Conclusions and Relevance Compared with dermatologists, PAs performed more skin biopsies per case of skin cancer diagnosed and diagnosed fewer melanomas in situ, suggesting that the diagnostic accuracy of PAs may be lower than that of dermatologists. Although the availability of PAs may help increase access to care and reduce waiting times for appointments, these findings have important implications for the training, appropriate scope of practice, and supervision of PAs and other nonphysician practitioners in dermatology.
[1]
Jonhan Ho,et al.
Estimating the cost of skin cancer detection by dermatology providers in a large health care system
,
2017,
Journal of the American Academy of Dermatology.
[2]
J. Grant-Kels,et al.
Ethics of utilizing nurse practitioners and physician's assistants in the dermatology setting.
,
2012,
Clinics in dermatology.
[3]
J. Resneck.
Dermatology Practice Consolidation Fueled by Private Equity Investment: Potential Consequences for the Specialty and Patients.
,
2018,
JAMA dermatology.
[4]
KyungMann Kim,et al.
Biopsy Use in Skin Cancer Diagnosis: Comparing Dermatology Physicians and Advanced Practice Professionals.
,
2015,
JAMA dermatology.
[5]
Alison Ehrlich,et al.
Trends in dermatology practices and the implications for the workforce
,
2017,
Journal of the American Academy of Dermatology.
[6]
D. Ekwueme,et al.
Melanoma treatment costs: a systematic review of the literature, 1990-2011.
,
2012,
American journal of preventive medicine.
[7]
B. Coldiron,et al.
Scope of physician procedures independently billed by mid-level providers in the office setting.
,
2014,
JAMA dermatology.
[8]
M. Weinstock,et al.
Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations.
,
2012,
Archives of dermatology.